Gsa Capital Partners LLP Eton Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.55 - $4.38 $62,411 - $107,200	-24,475 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$3.43 - $4.69 $52,623 - $71,953	-15,342 Reduced 38.53%	24,475 $107,000
Q4 2021 Feb 14, 2022	SELL	$3.66 - $6.59 $155,539 - $280,055	-42,497 Reduced 51.63%	39,817 $171,000
Q3 2021 Nov 12, 2021	BUY	$4.2 - $6.26 $104,651 - $155,980	24,917 Added 43.41%	82,314 $415,000
Q2 2021 Aug 05, 2021	BUY	$5.71 - $8.85 $98,971 - $153,397	17,333 Added 43.26%	57,397 $354,000
Q1 2021 May 10, 2021	BUY	$6.93 - $10.07 $277,643 - $403,444	40,064 New	40,064 $293,000

9.44M

261K

500

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $322M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.